{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:33:11Z","timestamp":1755221591718,"version":"3.43.0"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,8,8]]},"DOI":"10.1248\/bpb.b25-00138","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T22:08:15Z","timestamp":1754604495000},"page":"1191-1198","source":"Crossref","is-referenced-by-count":0,"title":["Enhancement of Immune Modulation by Toll-Like Receptor 9 Adjuvant Combination Subcutaneous Immunotherapy for Japanese Cedar Pollinosis"],"prefix":"10.1248","volume":"48","author":[{"given":"Daichi","family":"Utsumi","sequence":"first","affiliation":[{"name":"Innovation Research Laboratory, Torii Nihonbashi Bldg., 3\u20134\u20131 Nihonbashi-Honcho, Chuo-ku, Tokyo 103\u20138439, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Innovation Research Laboratory, Torii Nihonbashi Bldg., 3\u20134\u20131 Nihonbashi-Honcho, Chuo-ku, Tokyo 103\u20138439, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsuhara","sequence":"additional","affiliation":[{"name":"Innovation Research Laboratory, Torii Nihonbashi Bldg., 3\u20134\u20131 Nihonbashi-Honcho, Chuo-ku, Tokyo 103\u20138439, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsushi","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hyogo College of Medicine, Nishinomiya, Hyogo 663\u20138501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken J.","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108\u20138639, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyo","family":"Ohashi-Doi","sequence":"additional","affiliation":[{"name":"Innovation Research Laboratory, Torii Nihonbashi Bldg., 3\u20134\u20131 Nihonbashi-Honcho, Chuo-ku, Tokyo 103\u20138439, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. <i>Allergy<\/i>, <b>76<\/b>, 3383\u20133389 (2021).","DOI":"10.1111\/all.15044"},{"key":"2","unstructured":"2) Brozek JL, Bousquet J, Agache I, <i>et al<\/i>. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. <i>J. Allergy Clin. Immunol.<\/i>, <b>140<\/b>, 950\u2013958 (2017)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ohashi-Doi K, Utsumi D, Mitobe Y, Fujinami K. Japanese cedar pollen allergens in Japan. <i>Curr. Protein Pept. Sci.<\/i>, <b>23<\/b>, 837\u2013850 (2022).","DOI":"10.2174\/1389203723666220930155719"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Noon L. Prophylactic inoculation against hay fever. <i>Lancet<\/i>, <b>177<\/b>, 1572\u20131573 (1911).","DOI":"10.1016\/S0140-6736(00)78276-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kucuksezer UC, Ozdemir C, Cevhertas L, Ogulur I, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and allergen tolerance. <i>Allergol. Int.<\/i>, <b>69<\/b>, 549\u2013560 (2020).","DOI":"10.1016\/j.alit.2020.08.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Halken S, Larenas-Linnemann D, Roberts G, <i>et al<\/i>. EAACI guidelines on allergen immunotherapy: prevention of allergy. <i>Pediatr. Allergy Immunol.<\/i>, <b>28<\/b>, 728\u2013745 (2017).","DOI":"10.1111\/pai.12807"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. <i>J. Allergy Clin. Immunol.<\/i>, <b>140<\/b>, 1485\u20131498 (2017).","DOI":"10.1016\/j.jaci.2017.10.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Otsuka K, Otsuka H, Matsune S, Okubo K. Allergen-specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season. <i>Immun. Inflamm. Dis.<\/i>, <b>8<\/b>, 258\u2013266 (2020).","DOI":"10.1002\/iid3.301"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y. Disease-modifying effect of Japanese cedar pollen sublingual immunotherapy tablets. <i>J. Allergy Clin. Immunol. Pract.<\/i>, <b>9<\/b>, 4103\u20134116, e4114 (2021).","DOI":"10.1016\/j.jaip.2021.06.060"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Pohlit H, Bellinghausen I, Frey H, Saloga J. Recent advances in the use of nanoparticles for allergen-specific immunotherapy. <i>Allergy<\/i>, <b>72<\/b>, 1461\u20131474 (2017).","DOI":"10.1111\/all.13199"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jensen-Jarolim E, Roth-Walter F, Jordakieva G, Pali-Scholl I. Allergens and adjuvants in allergen immunotherapy for immune activation, tolerance, and resilience. <i>J. Allergy Clin. Immunol. Pract.<\/i>, <b>9<\/b>, 1780\u20131789 (2021).","DOI":"10.1016\/j.jaip.2020.12.008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Utsumi D, Sugawara T, Hashida K, Yasuhara Y, Fujinami K, Lund K, Ohashi-Doi K. Reduced anaphylactic potential of denatured pullulan-conjugated Cry j 1. <i>Int. Immunopharmacol.<\/i>, <b>99<\/b>, 108026 (2021).","DOI":"10.1016\/j.intimp.2021.108026"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Montamat G, Leonard C, Poli A, Klimek L, Ollert M. CpG adjuvant in allergen-specific immunotherapy: finding the sweet spot for the induction of immune tolerance. <i>Front. Immunol.<\/i>, <b>12<\/b>, 590054 (2021).","DOI":"10.3389\/fimmu.2021.590054"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. <i>Nat. Rev. Immunol.<\/i>, <b>4<\/b>, 249\u2013258 (2004).","DOI":"10.1038\/nri1329"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miyamoto N, Fujii S, Mochizuki S, Sakurai K, Sakaguchi N, Koiwai K. A two-component micelle with emergent pH responsiveness by mixing dilauroyl phosphocholine and deoxycholic acid and its delivery of proteins into the cytosol. <i>Colloids Surf. B Biointerfaces<\/i>, <b>154<\/b>, 246\u2013252 (2017).","DOI":"10.1016\/j.colsurfb.2017.03.013"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K. pH-Responsive micelle-based cytoplasmic delivery system for induction of cellular immunity. <i>Vaccines<\/i> (Basel), <b>5<\/b>, 41 (2017).","DOI":"10.3390\/vaccines5040041"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. <i>PLoS Biol<\/i>., <b>8<\/b>, e1000412 (2010).","DOI":"10.1371\/journal.pbio.1000412"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. <i>J. Allergy Clin. Immunol.<\/i>, <b>71<\/b>, 77\u201386 (1983).","DOI":"10.1016\/0091-6749(83)90550-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kanno T, Adachi Y, Ohashi-Doi K, Matsuhara H, Hiratsuka R, Ishibashi KI, Yamanaka D, Ohno N. Latent 1,3-beta-D-glucan acts as an adjuvant for allergen-specific IgE production induced by Japanese cedar pollen exposure. <i>Allergol. Int.<\/i>, <b>70<\/b>, 105\u2013113 (2021).","DOI":"10.1016\/j.alit.2020.08.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shima K, Koya T, Tsukioka K, Sakagami T, Hasegawa T, Fukano C, Ohashi-Doi K, Watanabe S, Suzuki E, Kikuchi T. Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts. <i>Allergol. Int.<\/i>, <b>66<\/b>, 89\u201396 (2017).","DOI":"10.1016\/j.alit.2016.05.012"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. <i>J. Immunol.<\/i>, <b>162<\/b>, 6284\u20136293 (1999).","DOI":"10.4049\/jimmunol.162.10.6284"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ito S, Hirobe S, Kawakita T, Saito M, Quan YS, Kamiyama F, Ishii KJ, Nagao M, Fujisawa T, Tachibana M, Okada N. Characteristic of K3 (CpG-ODN) as a transcutaneous vaccine formulation adjuvant. <i>Pharmaceutics<\/i>, <b>12<\/b>, 267 (2020).","DOI":"10.3390\/pharmaceutics12030267"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. <i>J. Immunol.<\/i>, <b>166<\/b>, 2372\u20132377 (2001).","DOI":"10.4049\/jimmunol.166.4.2372"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Guan H, Nagarkatti PS, Nagarkatti M. Role of CD44 in the differentiation of Th1 and Th2 cells: CD44-deficiency enhances the development of Th2 effectors in response to sheep RBC and chicken ovalbumin. <i>J. Immunol.<\/i>, <b>183<\/b>, 172\u2013180 (2009).","DOI":"10.4049\/jimmunol.0802325"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. <i>Kidney Int<\/i>., <b>55<\/b>, 1198\u20131216 (1999).","DOI":"10.1046\/j.1523-1755.1999.00369.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. <i>J. Immunol.<\/i>, <b>160<\/b>, 2555\u20132559 (1998).","DOI":"10.4049\/jimmunol.160.6.2555"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. <i>J. Exp. Med.<\/i>, <b>186<\/b>, 1623\u20131631 (1997).","DOI":"10.1084\/jem.186.10.1623"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Muller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kundig TM. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I\/IIa clinical trial. <i>Clin. Exp. Allergy<\/i>, <b>39<\/b>, 562\u2013570 (2009).","DOI":"10.1111\/j.1365-2222.2008.03191.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane E, Layhadi JA, Wurtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. <i>J. Allergy Clin. Immunol.<\/i>, <b>148<\/b>, 1061\u20131071 e1011 (2021).","DOI":"10.1016\/j.jaci.2021.03.030"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Komlosi ZI, Kovacs N, Sokolowska M, van de Veen W, Akdis M, Akdis CA. Highlights of novel vaccination strategies in allergen immunotherapy. <i>Immunol. Allergy Clin. North Am.<\/i>, <b>40<\/b>, 15\u201324 (2020).","DOI":"10.1016\/j.iac.2019.09.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. <i>J. Allergy Clin. Immunol.<\/i>, <b>106<\/b>, 124\u2013134 (2000).","DOI":"10.1067\/mai.2000.107927"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Joshi VB, Adamcakova-Dodd A, Jing X, Wongrakpanich A, Gibson-Corley KN, Thorne PS, Salem AK. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy. <i>AAPS J.<\/i>, <b>16<\/b>, 975\u2013985 (2014).","DOI":"10.1208\/s12248-014-9624-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Klimek L, Willers J, Hammann-Haenni A, Pfaar O, Stocker H, Mueller P, Renner WA, Bachmann MF. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. <i>Clin. Exp. Allergy<\/i>, <b>41<\/b>, 1305\u20131312 (2011).","DOI":"10.1111\/j.1365-2222.2011.03783.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. <i>J. Allergy Clin. Immunol.<\/i>, <b>133<\/b>, 621\u2013631 (2014).","DOI":"10.1016\/j.jaci.2013.12.1088"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Bush RK. Advances in allergen immunotherapy in 2015. <i>J. Allergy Clin. Immunol.<\/i>, <b>138<\/b>, 1284\u20131291 (2016).","DOI":"10.1016\/j.jaci.2016.09.007"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/8\/48_b25-00138\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T03:52:48Z","timestamp":1754711568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/8\/48_b25-00138\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00138","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"b25-00138"}}